I
0.196
0.00 (-1.51%)
| Previous Close | 0.199 |
| Open | 0.196 |
| Volume | 1,566,300 |
| Avg. Volume (3M) | 2,024,137 |
| Market Cap | 357,151,200 |
| Price / Sales | 112.79 |
| 52 Weeks Range | |
| Earnings Date | 29 Nov 2024 |
| Profit Margin | 194.33% |
| Operating Margin (TTM) | -233.91% |
| Diluted EPS (TTM) | -0.010 |
| Quarterly Revenue Growth (YOY) | -18.70% |
| Quarterly Earnings Growth (YOY) | -47.50% |
| Total Debt/Equity (MRQ) | 189.99% |
| Current Ratio (MRQ) | 0.010 |
| Operating Cash Flow (TTM) | -6.53 M |
| Levered Free Cash Flow (TTM) | -128.15 M |
| Return on Assets (TTM) | -0.65% |
| Return on Equity (TTM) | 1.76% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Specialty Retail (HK) | Mixed | Mixed |
| Specialty Retail (Global) | Mixed | Bearish | |
| Stock | INNOVATIVE PHAR | - | - |
AIStockmoo Score
-0.8
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | -1.0 |
| Technical Moving Averages | -1.5 |
| Technical Oscillators | -0.5 |
| Average | -0.75 |
Similar Stocks
| Stock | Market Cap | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| INNOVATIVE PHAR | 357 M | - | - | - |
| QIDIAN GUOFENG | 6 B | - | - | 27.71 |
| SA SA INT'L | 2 B | 4.31% | 27.50 | 1.55 |
| GOME RETAIL | 928 M | - | - | 0.210 |
| IH RETAIL | 681 M | 10.43% | 7.83 | 0.750 |
| MI MING MART | 95 M | 9.09% | 8.50 | 1.42 |
|
Innovative Pharmaceutical Biotech Ltd is a Hong Kong-based investment holding company principally engaged in pharmaceuticals and biotechnology businesses. The company has two operating segments; Trading of beauty products in Hong Kong and Research, development, and commercialisation of the oral insulin product. The company generates almost all of its revenue from Hong Kong. |
|
| Sector | Consumer Cyclical |
| Industry | Specialty Retail |
| Investment Style | Small Value |
| % Held by Insiders | 44.03% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |